1. There are a total of 38,321 records this release, up from 38,272 in the previously released version. This version incorporates all of the applicable LOINC changes in version 2.69 as published by Regenstrief in December 2020.
2. 37,422 records have been translated to French, up from 37,374 in the last version. Terms that are marked ‘Review Draft’ should be reviewed before they are used as the translation has not been previously published. Terms that are marked as ‘Complete’ have been previously published.
3. 101 records were modified in English for this release and are marked as R05.13.00_2.69
a. 9 records are of the change type Major for English changes.
b. 4 records are of the change type Minor for English changes..
c. 39 records are of the change type Name for English changes.
4. 49 new records were added for the English version.
5. 100 records were modified in French for this release and are marked as R05.13.00_2.69
a. 10 records are of the change type Major for the French translation.
b. 2 records are of the change type Minor for the French translation.
c. 36 records are of the change type Name for the French translation.
d. 4 corrections were made to Viewer Names
6. 48 new records were added for the French version.
7. Both languages contain a number of codes that only have changes in the other language; those are identified as ‘No Change’.
Of specific interest in this release , current implementers may want to review these changes:
A number of changes were not identified as R05.13.00_2.69, they are based on community input and internal review which includes:
25 terms required TALLMAN lettering corrections to Component, Pan-Canadian Compenent Name, pan-Canadian Name and Example Viewer. The TALLMAN lettering for drugs is based on recommendations from the Institute for Safe Medication Practices and ISMP Canada, please see the new list of LOINC Terms with edits to TALLMAN lettering to identify the changes.